Form 8-K - Current report:
SEC Accession No. 0000950170-25-087352
Filing Date
2025-06-17
Accepted
2025-06-17 16:07:43
Documents
15
Period of Report
2025-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aplt-20250615.htm   iXBRL 8-K 75120
2 EX-99.1 aplt-ex99_1.htm EX-99.1 115098
3 EX-99.2 aplt-ex99_2.htm EX-99.2 208457
4 EX-99.3 aplt-ex99_3.htm EX-99.3 30014
5 GRAPHIC img58575630_0.jpg GRAPHIC 16201
6 GRAPHIC img60422672_0.jpg GRAPHIC 16201
  Complete submission text file 0000950170-25-087352.txt   648297

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20250615.xsd EX-101.SCH 23938
17 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20250615_htm.xml XML 4526
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 251053374
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)